SEC Form 4 research
| Issuer | Moderna, Inc. |
|---|---|
| Tickers | MRNA |
| Reporting owners | 36 |
| Officers and directors | 15 |
| Last public filing | 2026-10-16 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-16 | 2026-10-15 | Hoge Stephen | S | 39,145 | $220.72 | Not reported |
| 2026-10-16 | 2026-10-14 | Hoge Stephen | S | 450 | $214.15 | Not reported |
| 2026-10-16 | 2026-10-14 | Hoge Stephen | S | 38,774 | $213.47 | Not reported |
| 2026-09-16 | 2026-09-15 | Hoge Stephen | S | 40,281 | $146.07 | Not reported |
| 2026-09-16 | 2026-09-14 | Hoge Stephen | S | 40,294 | $144.13 | Not reported |
| 2026-09-14 | 2026-09-10 | Mock James M | S | 15,000 | $134.49 | Not reported |
| 2026-09-14 | 2026-09-10 | Mock James M | S | 19,836 | $134.49 | Not reported |
| 2026-09-03 | 2026-09-01 | Klinger Shannon Thyme | S | 3,471 | $139.95 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.